Clinical Study Results
Research Sponsor: AstraZeneca
Treatment Studied: Durvalumab
Study Purpose: This study was done to learn about the safety
of durvalumab in participants with cancer
of the urinary tract that has spread
Protocol Number: D4191C00068
Thank you
Thank you for taking part in the clinical study for the study treatment durvalumab, also called
MEDI4736.
You and all of the participants helped researchers learn more about durvalumab to help people
with cancer of the urinary tract that has spread outside the urinary tract.
AstraZeneca sponsored this study and believes it is important to share the results of the study
with you and the public. An independent non-profit organization called CISCRP helped prepare
this summary of the study results for you. We hope it helps you understand and feel proud of
your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.
1